Close

Cowen Downgrades Imago Biosciences Inc (IMGO) to Market Perform Following Takeover

November 21, 2022 5:40 PM EST
Get Alerts IMGO Hot Sheet
Price: $36.01 --0%

Rating Summary:
    1 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE

Cowen analyst Marc Frahm downgraded Imago Biosciences Inc (NASDAQ: IMGO) from Outperform to Market Perform with a price target of $36.00 after the company agreed to be acquired by Merck.

For an analyst ratings summary and ratings history on Imago Biosciences Inc click here. For more ratings news on Imago Biosciences Inc click here.

Shares of Imago Biosciences Inc closed at $17.40 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Cowen & Co